The following mild to moderate side effects may occur as the body adjusts to the medication: Nausea Vomiting Diarrhea Constipation Decreased appetite Rare but potential health risks may include: Allergic reactions (e.g., rash, itching, swelling, or difficulty breathing) Pancreatitis Hypoglycemia (low blood sugar) Gallbladder issues Kidney function issues Thyroid tumors While monitoring potential side effects, its essential to focus on the positive aspects
There is no clinical requirement for you to change your own diet
Early trials show significant weight loss and metabolic improvements
Compared to bupropion-naltrexone, GLP-1 agonists were associated with a nine times higher risk of pancreatitis, or inflammation of the pancreas, which can cause severe abdominal pain
Instead, we use Rybelsus tablets, which are FDA-approved for oral semaglutide administration
IV glutathione in pregnancy and nursing